Intech Investment Management LLC Has $2.28 Million Holdings in Danaher Co. (NYSE:DHR)

Intech Investment Management LLC lifted its position in shares of Danaher Co. (NYSE:DHR) by 33.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 9,938 shares of the conglomerate’s stock after purchasing an additional 2,483 shares during the quarter. Intech Investment Management LLC’s holdings in Danaher were worth $2,281,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Generali Asset Management SPA SGR acquired a new stake in shares of Danaher during the 4th quarter worth approximately $10,875,000. Horizon Investments LLC lifted its position in shares of Danaher by 108.0% during the 4th quarter. Horizon Investments LLC now owns 19,303 shares of the conglomerate’s stock worth $4,431,000 after buying an additional 10,021 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Danaher by 29.7% during the 4th quarter. Thrivent Financial for Lutherans now owns 755,738 shares of the conglomerate’s stock worth $173,560,000 after buying an additional 173,032 shares during the period. Tocqueville Asset Management L.P. lifted its position in shares of Danaher by 33.5% during the 4th quarter. Tocqueville Asset Management L.P. now owns 45,838 shares of the conglomerate’s stock worth $10,522,000 after buying an additional 11,498 shares during the period. Finally, Edgemoor Investment Advisors Inc. lifted its position in shares of Danaher by 2.2% during the 4th quarter. Edgemoor Investment Advisors Inc. now owns 7,269 shares of the conglomerate’s stock worth $1,669,000 after buying an additional 155 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 10.90% of the company’s stock.

Danaher Stock Down 0.1 %

Shares of Danaher stock opened at $210.14 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The business has a fifty day simple moving average of $217.92 and a 200 day simple moving average of $239.26. The stock has a market cap of $150.19 billion, a PE ratio of 39.80, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm earned $2.09 earnings per share. Research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s payout ratio is presently 24.24%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Friday, March 14th. Jefferies Financial Group cut their target price on Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Guggenheim initiated coverage on Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Finally, Citigroup cut their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $277.76.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.